Title: Study of gut microbiome signatures in COVID-19.

Design: Longitudinal laboratory-based prospective study.

Registration Number: Verona cohort registered on ClinicalTrials.gov

Primary Objective: to assess changes in the gut microbiome composition over time according to disease severity and treatment.

Secondary Objective(s): to find markers of microbiome composition correlated to immunological markers of infections; to assess changes in microbiome according to coinfections.

Interested in collaboration? Contact: Elda Righi (elda.righi@univr.it).

Publications: Submitted